News und Analysen
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2019 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2019 results on Wednesday, Feb. 26
CommonSpirit Health Chooses Premier Inc. to Clinically Integrate its Newly Merged Supply Chain
CommonSpirit Health will be partnering with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, to achieve operational excellence as it undergoes the complex integration of its
Evotec: Neue Top-Allianz – Anleger im Glück
Der News-Reigen setzt sich fort: Mit der auf Krebstherapien spezialisierten Indivumed initiiert Evotec (WKN: 566480) eine zweite Forschungsallianz, wie der TecDAX-Konzern heute mitteilt.
Konkret
Charles River Laboratories Schedules Fourth-Quarter 2019 Earnings and 2020 Guidance Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2019 financial results and provide 2020 guidance on Tuesday, February 11th, before the market
Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Allegheny General Hospital
Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Novocure (NASDAQ: NVCR) announced today that the State of Israel Ministry of Health has added Optune in combination with temozolomide to the Israeli medical services basket for the treatment of
Chemed To Report Fourth-Quarter 2019 Earnings February 18, Related Conference Call To Be Held On February 19
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2019, on Tuesday, February 18, 2020, following the close of trading on
Evotec: Management stapelt höher
Tolle Neuigkeiten für Aktionäre: Evotec (WKN: 566480) hebt seine EBITDA-Prognose für 2019 an. Die Aktie reagiert merkwürdig.
Evotec verbessert seine Einschätzung nicht nur marginal, sondern
Qiagen: Hier braut sich was zusammen!
Die Aktie von Qiagen (WKN: A2DKCH) begab sich Ende letzten Jahres auf eine regelrechte Achterbahnfahrt. Dafür gab es auch gute Gründe, über die wir Sie hier auf sharedeals.de stets auf dem Laufenden
BB Biotech: Ausschau nach „lukrativen Anlagechancen“
BB Biotech (WKN: A0NFN3) publiziert heute seine ersten Zahlen für das abgelaufene Geschäftsjahr. Aktionäre können sich freuen, denn als Dividende will die Schweizer Gesellschaft 3,40 CHF pro Aktie
Cannabis-Roundup: Canopy Growth & Aurora Cannabis
Investoren strömen wieder in den Sektor. In den letzten Tagen konnten die Aktien von Canopy Growth (WKN: A140QA), Aurora Cannabis (WKN: A12GS7) oder Tilray (WKN: A2JQSC) stark hinzugewinnen.
Das
Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive partnership with Fios Genomics, a leading provider of bioinformatics data analysis
Morphosys: Wer hätte das gedacht?
Morphosys-Aktien (WKN: 663200) verloren gestern im Handelsverlauf fast 23 Euro im Xetra-Handel. Ein so eklatanter Rutsch kam wohl auch für pessimistische Anleger überraschend.
Egal, was der
Evotec: Es geht Schlag auf Schlag
Ausnahmsweise ist die von Evotec (WKN: 566480) im Rahmen seiner heutigen Pressemitteilungen kommunizierte hochkarätige Forschungspartnerschaft nur eine (positive) Randnotiz. Diesmal geht es primär
ICON Issues Financial Guidance for Full Year 2020
ICON plc (NASDAQ: ICLR), global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
QIAGEN Builds on Global Collaboration With Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration to develop tissue-based companion diagnostics for Amgen’s investigational cancer treatment AMG 510
QIAGEN erweitert globale Zusammenarbeit mit Amgen zur Entwicklung von Begleitdiagnostika bei nicht-kleinzelligem Lungenkrebs
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute eine strategische Zusammenarbeit zur Entwicklung von gewebebasierten Begleitdiagnostika für Amgens Krebsmedikament AMG 510 bekannt
ICON plc to Present at 38th Annual J.P. Morgan Healthcare Conference and Issue Financial Guidance for Full Year 2020
ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates
Charles River (NYSE: CRL) today announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited (“Takeda”). Together, Charles River and Takeda will launch multiple
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday
Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2019. Novocure plans to discuss these
Morphosys: Milliarden für Anti-Krebs-Blockbuster
Morphosys-Aktien (WKN: 663200) steigen im Xetra-Handel auf bis zu 146,30 Euro. Grund ist ein milliardenschwerer Deal für den firmeneigenen Anti-Krebs-Wirkstoff Tafasitamab mit dem Biopharma-Bluechip
Premier Inc. to Report Fiscal 2020 Second-Quarter Results and Host Conference Call Before Market Opens on February 4
Premier Inc. (NASDAQ: PINC) plans to report fiscal 2020 second-quarter financial results the morning of Feb. 4, 2020, followed by a conference call at 8 a.m. ET to discuss the results.
Conference
QIAGEN N.V. to Report Fourth Quarter and Full Year 2019 Results
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans as previously announced to release its report on results for the fourth quarter and full-year 2019 on Tuesday
QIAGEN Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the 2,500th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories